Harnessing the power of proteomics
SomaLogic is fostering the discovery of effective and safer treatments for patients while empowering more accurate diagnosis, prevention, and treatment of disease through the next generation of proteomics.
Revolutionizing life sciences and healthcare
Founded in 2000, SomaLogic is a global leader in proteomics. Powered by an industry-leading technology platform and one of the largest clinical proteomic database in the world, we aim to revolutionize precision medicine to help address unmet medical needs.
We understand the importance of real-time data and actionable information when it comes to health, which is why we provide patients with knowledge on their current health status through analyzing their personal protein data.
SomaLogic’s pioneering platform provides more coverage of the proteome than any other technology. SomaLogic currently measures approximately 7,000 proteins, more than twice as many as other proteomic technology platforms, and we are quickly moving toward 10,000 proteins. That’s half of the approximately 20,000 proteins in your body.
The proprietary SomaScan® Assay measures proteins with high specificity, low variance and high reproducibility, which enables the possibility of faster, more precise drug discovery.
SomaLogic’s A.I. and machine learning-powered bioinformatics algorithms, operated in tandem with the company’s database of more than 450,000 protein samples, helped to create a growing suite of SomaSignal™ tests. These tests are clinical proteomic diagnostics that provide additional insights into the current health status of patients and the future risk of conditions and diseases with a small blood sample.
By understanding the intricacies of what goes on in our body, we strive to relieve human suffering and ultimately prolong human life.
The dynamics of proteomics translates into:
Life sciences advancements
Proteomics is powering transformational research that discovers life-changing drugs and brings safer and more effective treatments to patients faster.
Proteomics is transforming the continuum of care from improving the accuracy of prognostic and diagnostic testing to uncovering new targeted treatment options for patients stratified by risk of diseases through advances in precision medicine.